Sacroiliac joints (SI) are joints
between the sacrum and ilium bones of the pelvis. The sacrum supports the spine
and ilium bone supports sacrum. The sacroiliac joint is highly dependent on its
strong ligamentous structure for providing support and stability to complete
human body. Commonly observed conditions for which SI joint fusion is indicated
include sacroiliac joint dysfunction, sacroiliac joint disruption, and
degenerative sacroilitis. Sacroilitis is inflammation or dysfunction of the
sacroiliac joint which could result in the unilateral low back pain. Sacroiliac
joint dysfunction can be diagnosed using provocative and non-provocative
maneuvers. SI joint dysfunction can be treated with minimally invasive surgery
performed in either of the two ways: immediate fixation or SI joint fusion.
Sacroiliac fusion systems are intended to stabilize the sacroiliac joint and
provide an environment for fusion. During immediate fixation, an implant is
placed across the joints. Bone grafts can be delivered within the device to
promote fusion. Sacroiliac fusion surgery is gaining popularity among
physicians to treat the pain related to the sacroiliac joint. According to
SI-Bone, Inc., 82% of patients were satisfied with SI joint fusion surgery.
Hence, patient satisfaction and least requirement of repetition of the
procedure are likely to increase demand for sacroiliac fusion systems in the
next few years.
Read Report Overview: https://www.transparencymarketresearch.com/sacroiliac-fusion-implants-market.html
Release of the treatment guidelines by
the North American Spine Society and the International Society for the
Advancement of Spinal Surgery and favorable reimbursement policies for the
procedure by the U.S. Medicare are expected to increase the adoption of
sacroiliac fusion surgeries during the forecast period. According to recent statistics
released by BIBA Medical Ltd., about 18% of lower back pain is associated with
the dysfunction of the sacroiliac joint. Sedentary lifestyles resulting in
hypo-motility of the joint is the major reason for the rise in prevalence of
the disease across the globe. Hence, rise in prevalence of the disease,
increase in adoption of minimally invasive fusion procedure, economic growth,
surge in per capita health care spending, and increase in the number of skilled
orthopedic surgeons are anticipated to drive the sacroiliac fusion implants
market during the forecast period. Sacroiliac joint fusion technique is not
new; however, its penetration has been limited due to extensive nature of the
open fusion surgery and lack of consistent data to prove the effectiveness of
the minimally invasive procedure. Moreover, lack of awareness in the developing
regions and high cost of the procedure is projected to restrain the sacroiliac
fusion implants market during the forecast period.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=63636
The global sacroiliac fusion implants
market can be segmented based on product, surgery type, end-user, and region.
In terms of product, the sacroiliac fusion implants market can be classified
into triangular implants, porous implants, hollow modular screws, titanium
coated implants, titanium cages, and allograft dowels. Based on surgery type, the
global sacroiliac joint fusion implants market can be bifurcated into lateral
transarticular surgery and posterior surgery. In terms of end-user, the
sacroiliac fusion implants market can be divided into hospitals, orthopedic
clinics, ambulatory surgery centers, and others. The hospitals segment is
anticipated to dominate the global sacroiliac fusion implants market, owing to
high preference for hospitals due to availability of various facilities under
one roof and favorable reimbursement scenario.
Request for Analysis of COVID19 Impact on Sacroiliac Fusion Implants Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=63636
Based on region, the global sacroiliac
fusion implants market can be segmented into North America, Europe, Asia
Pacific, Latin America, and Middle East & Africa. North America is a
leading market for sacroiliac fusion implants owing to the presence of large
geriatric population and rise in prevalence of SI joint dysfunction. High
health care spending, rise in the number of minimally invasive procedures
performed in the region, and high adoption of advanced technologies by the
population are expected to boost sacroiliac fusion implants market growth in
North America. Europe and Asia Pacific are likely to experience increased
market traction due to rise in the number cases of SI joint disability and
pain. Additionally, surge in adoption of SI joint fusion surgery among
surgeons, economic empowerment of emerging regions such as Asia Pacific, Latin
America, and Middle East & Africa leading to an increase in affordability
for minimally invasive surgery procedure, and rise in the number of
sports-related injuries are anticipated to contribute to the growth of the
market in emerging regions.
Pre-Book Sacroiliac Fusion Implants Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=63636<ype=S
Key players operating in the global
total sacroiliac fusion implants market include RTI Surgical, Inc., Medtronic,
SI-BONE, Inc., Camber Spine, Zimmer Biomet, and Xtant Medical. These players
focus on expanding product portfolios through mergers and acquisitions. For
instance, in January 2018, RTI Surgical, Inc. signed an agreement to acquire
Zyga Technology, Inc., a leading medical device company which has developed
SImmetry Sacroiliac Joint Fusion System.
More Trending Reports by Transparency Market Research:
About Us
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
